International Myeloma Working Group molecular classification of multiple myeloma: spotlight reviewRafaël Fonseca, Hervé Avet‐Loiseau, Brian G.M. Durie et al.|Leukemia|2009Cited by 877
Mechanism of action of immunomodulatory drugs (IMiDS) in multiple myelomaHang Quach, H. Miles Prince, David Ritchie et al.|Leukemia|2009Cited by 586
Identification of novel mutational drivers reveals oncogene dependencies in multiple myelomaBrian A. Walker, Gareth J. Morgan, Konstantinos Mavrommatis et al.|Blood|2018Cited by 492
A high-risk, Double-Hit, group of newly diagnosed myeloma identified by genomic analysisBrian A. Walker, Gareth J. Morgan, Konstantinos Mavrommatis et al.|Leukemia|2018Cited by 452
International Myeloma Working Group Consensus Statement for the Management, Treatment, and Supportive Care of Patients With Myeloma Not Eligible for Standard Autologous Stem-Cell TransplantationAntonio Palumbo, Robert Z. Orlowski, S. Vincent Rajkumar et al.|Journal of Clinical Oncology|2014Cited by 384